← All indications
Pleural Effusion, Malignant
Presence of fluid in the PLEURAL CAVITY as a complication of malignant disease. Malignant pleural effusions often contain actual malignant cells.
Drugs by status
Approved for this indication (2)
Phase 4 trials (3)
Phase 3 trials (4)
Phase 2 trials (25)
- saracatinib
- doxycycline
- gemcitabine
- paclitaxel
- imatinib
- nivolumab
- naproxen
- pulvis talci
- carboplatin
- sitagliptin
- silver nitrate
- cetuximab
- talimogene laherparepvec
- tumor derived microparticles
- bortezomib
- docetaxel
- cediranib
- erlotinib
- recombinant adenoviral human p53 gene
- sodium chloride
- fludeoxyglucose f-18
- camrelizumab
- syngenon
- m701
- rso-021
Phase 1 trials (21)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (15)
- Abnoba
- Roche
- National Cancer Institute (NCI)
- Eastern Cooperative Oncology Group
- North Central Cancer Treatment Group
- Radiation Therapy Oncology Group
- University of South Florida
- Mayo Clinic
- University of California, Los Angeles
- University of Ulsan
- FORSCHUNGSINSTITUT HAVELHOHE
- Busan University
- Chiangmai University
- Chonnam National University
- People's Liberation Army of China
Organization Involved with Phase 2 Indications (23)
- Amgen
- AstraZeneca
- CareFusion
- Shenzhen SiBiono GeneTech Co.,Ltd
- Simcere Pharmaceutical Co., Ltd
- Huazhong University of Science and Technology
- Cancer and Leukemia Group B (CALGB)
- University of Washington
- Guangzhou Medical University
- McMaster University
- Radboud University
- University of Ottawa
- University of Rochester
- Assiut University
- Peking University
- University of Chicago
- Department of Defense
- Guangzhou University
- University of Oxford
- University of Texas at Houston
- University of Sao Paulo
- University of North Carolina at Chapel Hill
- BioSyngen Pte Ltd
Organization Involved with Phase 1 Indications (15)
- Genelux
- Candel Therapeutics
- University of Pennsylvania
- Cornell University
- Eastern Regional Medical Center
- Ohio State University
- University of Ibadan
- University of Lausanne
- University of Virginia
- CHU Henri Mondor
- Curie Institute
- City of Hope National Medical Center
- Technion University
- Clover Biopharmaceuticals
- Sichuan Clover Biopharmaceuticals, Inc.
Organization Involved with Other Experimental Indications (3)